17th January 2022 | Pharma Updates
Dolo 650 logs Rs 28.9 cr Sales Last Month
GSK’s Calpol has reported Rs 28 cr sales in the same month.
Lupin, Sun Pharma Recalls Products In US
Lupin is recalling 50832 bottles of gatifloxacin ophthalmic solution while on the other hand, Sun Pharma is recalling 696 bottles of pregabalin capsules.
Faculty Development Programme Organized at Chandigarh's Pharmacy College
A six-day programme on Advances in Pharmaceutical Research was held at Aryans College of Pharmacy, Rajpura Chandigarh.
Drug Companies to Add Itraconazole Linked Photosensitivity In Package Insert
This came after the recommendation of the review panel, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission which was placed before the SEC of CDSCO.
US FDA Warns of Health Problems Associated With the Purchase of Molnupiravir from Illegal Sources
If Merck’s experimental pill is purchased from unlicensed sources, it may contain no active or very little ingredient, which may result in no significant benefits, said FDA.
Domestic Manufacturing of Medical Devices Is a Big Opportunity: JB Chowhan
The focus on domestic manufacturing of medical devices is visible in the GoI’s initiatives like 100% FDI for medical devices.
India Marks 1 Year of Covid Vaccination
93% of India’s adult population was administered with one dose of Covid vaccine.
